EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Efferocytosis and Its Role in Rheumatic Diseases

Xiaoyu Tang, Yani Peng, Zenan Jiang, Bilian Yu, Daoquan Peng iD, Xi Xie, Fen Li iD, Yan Ge iD

Arthritis & Rheumatology · 2025

DOI: 10.1002/art.43268 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Xiaoyu Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Second Xiangya Hospital of Central South University and Clinical Medical Research Center for Systemic Auto…. Hauptthemen laut MEDLINE: Rheumatic Diseases, Phagocytosis, Apoptosis, Phagocytes. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University, Chinese Chronic Rheumatic Disease Research Project of China Primary Health Care Foundation, Natural Science Foundation of Changsha.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Efferocytosis, the process through which phagocytes clear apoptotic cells (ACs), has rapidly emerged as an expanding field of research. This multistep process involves recognizing, binding, internalizing, and degrading ACs. Efferocytosis clears ACs, preventing their secondary necrosis, generating anti‐inflammatory mediators, and promoting the resolution of inflammation. Appropriate efferocytosis is essential for preserving immune tolerance and preventing exposure to self‐antigens, whereas defective efferocytosis is linked to the onset of various rheumatic diseases. Here, we review the process of efferocytosis and its implications in common rheumatic diseases. This review focuses on the role of abnormal efferocytosis in the development and progression of systemic lupus erythematosus. We also summarize recent advances in understanding efferocytosis in other rheumatic diseases, including rheumatoid arthritis (RA), Sjögren disease, antineutrophil cytoplasmic antibody–associated vasculitis, systemic sclerosis, antiphospholipid syndrome, gout, and osteoarthritis. Notably, a clinical trial investigating AC infusion for refractory RA has been proposed, highlighting the therapeutic potential of targeting efferocytosis. In addition, emerging strategies—such as liver X receptor/peroxisome proliferator‐activated receptor agonists; DNase‐containing nanoparticles; Tyro3, Axl, and Mer receptor agonists; and anti‐CD47 antibodies—show promise, although most remain at the preclinical stage. Despite the challenges posed by the immune system's complexity and the pleiotropic functions of efferocytosis‐related molecules, growing evidence supports efferocytosis as a potential therapeutic target in rheumatic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic DiseasesPhagocytosisApoptosisPhagocytesHumansArthritis, RheumatoidLupus Erythematosus, SystemicAnimalsSjogren's SyndromeEfferocytosis

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Second Xiangya Hospital of Central South University and Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, Changsha, China.
  • National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Hunan Engineering Research Center of Cell Therapy for Diabetes, and Department of Metabolism and En…
  • Department of Cardiothoracic Surgery, Hunan Children's Hospital, Changsha, China.
  • Hunan Key Laboratory of Cardiometabolic Medicine, Research Institute of Blood Lipid and Atherosclerosis, Central South University, Department of Cardiovascular Medicine, Second Xiangya Hospital of Central South Universi…

ORCID-Profile: Daoquan Peng, Fen Li, Yan Ge

Förderung

  • Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
  • Chinese Chronic Rheumatic Disease Research Project of China Primary Health Care Foundation
  • Natural Science Foundation of Changsha
  • National Natural Science Foundation of China

Zitieren

APA

Tang, X., Peng, Y., Jiang, Z., Yu, B., Peng, D., Xie, X., Li, F., & Ge, Y. (2025). Efferocytosis and Its Role in Rheumatic Diseases. Arthritis & Rheumatology. https://doi.org/10.1002/art.43268

Vancouver

Tang X, Peng Y, Jiang Z, Yu B, Peng D, Xie X, et al. Efferocytosis and Its Role in Rheumatic Diseases. Arthritis & Rheumatology. 2025. doi:10.1002/art.43268

BibTeX
@article{Tang2025,
  author = {Tang, Xiaoyu and Peng, Yani and Jiang, Zenan and Yu, Bilian and Peng, Daoquan and Xie, Xi and Li, Fen and Ge, Yan},
  title = {Efferocytosis and Its Role in Rheumatic Diseases},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  doi = {10.1002/art.43268}
}
Kostenlos starten →